Results 181 to 190 of about 555,884 (236)

Correction to: The role of government agencies and other actors in influencing access to medicines in three East African countries. [PDF]

Health Policy Plan
europepmc   +1 more source

Political Prioritization of Access to Medicines and Right to Health: Need for an Effective Global Health Governance Through Global Health Diplomacy Comment on "More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry's Role in Widening the Access Gap". [PDF]

Int J Health Policy Manag
Kumar Chattu V, Pushkaran A, Narayanan P.   +2 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Towards widening access to medicine

Medical Teacher, 2012
Dear SirDiversity at medical school would lead to a more culturally sensitive education process, vital in producing competent doctors capable of serving the UK's increasingly heterogeneous populati...
Alhafidz, Hamdan, Edward, Lea
openaire   +2 more sources

The new Access to Medicine Index

The Lancet, 2008
Tim Reed of Health Action International (Sept 13, p 890) seems less than fully content with the Access to Medicine Index published in June, 2008, because it “has turned out as an attractive new business tool for big pharma.” His disapproval is a bit premature and might be partly based on inaccurate information.
Mohammed K, Ali, K M Venkat, Narayan
  +7 more sources

Empower: Access to Medicine – Working Towards Early Access

Reviews on Recent Clinical Trials, 2015
Empower: Access to Medicine's contribution will document the founding of Empower: Access to Medicine and tactics used to create a lobbying campaign designed to facilitate the debate around barriers to medical innovation and patient access to medicines.
Jennifer Bryant, Pearson, James, Turgoose, James, Hargrave   +2 more
openaire   +2 more sources

Patent Funded Access to Medicines

Developing World Bioethics, 2014
AbstractInstead of impeding access to essential medicines in developing countries, the essay explores why and how patents can serve as a source of funding for the much needed access to medicine. Instead of a weakening of patents, prolonged protection periods are suggested in circumstances where there is widespread lack of access.
openaire   +2 more sources